Clinical trial
Bioequivalence and Safety Study of Vantobra and TOBI Nebulizer Solutions in Healthy Subjects
NCT01953367 is registered in ClinicalTrials.gov with Pari Pharma GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence and Safety Study of Vantobra and TOBI Nebulizer Solutions in Healthy Subjects
- Lead sponsor
- Pari Pharma GmbH
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- November 30, 2013
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.